An accurate method for the quantification of cytochrome C oxidase in tissue sections.

PubWeight™: 0.81‹?›

🔗 View Article (PMC 3644333)

Published in J Neurosci Methods on January 30, 2013

Authors

Miguel Melendez-Ferro1, Matthew W Rice, Rosalinda C Roberts, Emma Perez-Costas

Author Affiliations

1: Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, Sparks Center 865, 1720 7th Avenue South, Birmingham, AL 35294, USA. melendez@uab.edu

Articles cited by this

Nondroplet ultrastructural demonstration of cytochrome oxidase activity with a polymerizing osmiophilic reagent, diaminobenzidine (DAB). J Cell Biol (1968) 4.22

The use of c-fos as a metabolic marker in neuronal pathway tracing. J Neurosci Methods (1989) 3.15

c-Fos and related immediate early gene products as markers of activity in neuroendocrine systems. Front Neuroendocrinol (1993) 1.86

Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neuroscience (1989) 1.64

Anatomical markers of activity in neuroendocrine systems: are we all 'fos-ed out'? J Neuroendocrinol (2002) 1.37

Basal ganglia pathology in schizophrenia: dopamine connections and anomalies. J Neurochem (2010) 1.14

Quantitative mapping of cytochrome oxidase activity in the central auditory system of the gerbil: a study with calibrated activity standards and metal-intensified histochemistry. Brain Res (1994) 1.01

Metabolic activity of cerebellar and basal ganglia-thalamic neurons is reduced in parkinsonism. Brain (2007) 1.01

Cytochrome oxidase activity in the auditory system of the mouse: a qualitative and quantitative histochemical study. Neuroscience (1994) 0.99

Ultramicrospectrophotometric determination of cytochrome oxidase for quantitative histochemistry. J Biol Chem (1953) 0.97

Dopamine pathology in schizophrenia: analysis of total and phosphorylated tyrosine hydroxylase in the substantia nigra. Front Psychiatry (2012) 0.95

Brain cytochrome oxidase: purification, antibody production, and immunohistochemical/histochemical correlations in the CNS. J Neurosci (1989) 0.95

Bigenomic regulation of cytochrome c oxidase in neurons and the tight coupling between neuronal activity and energy metabolism. Adv Exp Med Biol (2012) 0.94

Abnormalities in the tricarboxylic acid (TCA) cycle in the brains of schizophrenia patients. Eur Neuropsychopharmacol (2010) 0.94

Neuronal expression of nuclear and mitochondrial genes for cytochrome oxidase (CO) subunits analyzed by in situ hybridization: comparison with CO activity and protein. J Neurosci (1991) 0.90

Consequences of nigrostriatal denervation on the functioning of the basal ganglia in human and nonhuman primates: an in situ hybridization study of cytochrome oxidase subunit I mRNA. J Neurosci (1997) 0.89

Dopaminergic control of kynurenate levels and N-methyl-D-aspartate toxicity in the developing rat striatum. Dev Neurosci (1998) 0.86

A 2-deoxyglucose study of the effects of dopamine agonists on the parkinsonian primate brain. Implications for the neural mechanisms that mediate dopamine agonist-induced dyskinesia. Brain (1992) 0.86

Functional activity of zona incerta neurons is altered after nigrostriatal denervation in hemiparkinsonian rats. Exp Neurol (2000) 0.84

Local cerebral metabolic effects of L-dopa therapy in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in monkeys. Proc Natl Acad Sci U S A (1987) 0.83

An optimized method for determining cytochrome oxidase activity in brain tissue homogenates. J Neurosci Methods (1993) 0.82

Patterns of FOS expression in the spinal cord and periaqueductal grey matter of 6OHDA-lesioned rats. Int J Neurosci (2008) 0.82

Induction of immediate early gene expression by high-frequency stimulation of the subthalamic nucleus in rats. Neuroscience (2006) 0.81

Mapping of mitochondrial metabolic competence by cytochrome oxidase and succinic dehydrogenase cytochemistry. J Histochem Cytochem (2001) 0.81

Effects of intralaminar thalamic nuclei lesion on glutamic acid decarboxylase (GAD65 and GAD67) and cytochrome oxidase subunit I mRNA expression in the basal ganglia of the rat. Eur J Neurosci (2002) 0.80

Improved contrast in histochemical detection of cytochrome oxidase: metallic ions protocol. J Neurosci Methods (1995) 0.78

Marked and variable inhibition by chemical fixation of cytochrome oxidase and succinate dehydrogenase in single motoneurons. J Histochem Cytochem (1989) 0.77

Early and late molecular events occurring following neuronal degeneration in the dopamine system. Adv Neurol (1993) 0.77

Articles by these authors

Human postmortem tissue: what quality markers matter? Brain Res (2006) 2.92

Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry (2003) 2.82

Genomic convergence analysis of schizophrenia: mRNA sequencing reveals altered synaptic vesicular transport in post-mortem cerebellum. PLoS One (2008) 2.22

Altered expression of genes involved in GABAergic transmission and neuromodulation of granule cell activity in the cerebellum of schizophrenia patients. Am J Psychiatry (2008) 2.13

Striatal mitochondria in subjects with chronic undifferentiated vs. chronic paranoid schizophrenia. Synapse (2011) 1.43

DISC1 immunoreactivity at the light and ultrastructural level in the human neocortex. J Comp Neurol (2006) 1.42

Downregulated kynurenine 3-monooxygenase gene expression and enzyme activity in schizophrenia and genetic association with schizophrenia endophenotypes. Arch Gen Psychiatry (2011) 1.22

Impaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia. Schizophr Bull (2010) 1.19

Higher expression of serotonin 5-HT(2A) receptors in the postmortem brains of teenage suicide victims. Am J Psychiatry (2002) 1.17

Chromatin alterations associated with down-regulated metabolic gene expression in the prefrontal cortex of subjects with schizophrenia. Arch Gen Psychiatry (2005) 1.17

Proinflammatory cytokines in the prefrontal cortex of teenage suicide victims. J Psychiatr Res (2011) 1.16

Regional alterations in RGS4 protein in schizophrenia. Synapse (2006) 1.15

Basal ganglia pathology in schizophrenia: dopamine connections and anomalies. J Neurochem (2010) 1.14

Brain-derived neurotrophic factor and tyrosine kinase B receptor signalling in post-mortem brain of teenage suicide victims. Int J Neuropsychopharmacol (2008) 1.12

Interstitial cells of the white matter in the dorsolateral prefrontal cortex in deficit and nondeficit schizophrenia. J Nerv Ment Dis (2003) 1.09

Abnormal expression and functional characteristics of cyclic adenosine monophosphate response element binding protein in postmortem brain of suicide subjects. Arch Gen Psychiatry (2003) 1.07

Basal ganglia dopamine loss due to defect in purine recycling. Neurobiol Dis (2007) 1.06

[(3)H]cAMP binding sites and protein kinase a activity in the prefrontal cortex of suicide victims. Am J Psychiatry (2002) 1.03

Regional expression of RGS4 mRNA in human brain. Eur J Neurosci (2004) 1.01

Postmortem brain tissue of depressed suicides reveals increased Gs alpha localization in lipid raft domains where it is less likely to activate adenylyl cyclase. J Neurosci (2008) 1.01

Modulation in activation and expression of phosphatase and tensin homolog on chromosome ten, Akt1, and 3-phosphoinositide-dependent kinase 1: further evidence demonstrating altered phosphoinositide 3-kinase signaling in postmortem brain of suicide subjects. Biol Psychiatry (2010) 1.00

Protein kinase A in postmortem brain of depressed suicide victims: altered expression of specific regulatory and catalytic subunits. Biol Psychiatry (2004) 0.99

Neurotrophin receptor activation and expression in human postmortem brain: effect of suicide. Biol Psychiatry (2008) 0.99

A Golgi study of neuronal architecture in a genetic mouse model for Lesch-Nyhan disease. Neurobiol Dis (2005) 0.95

Dopamine pathology in schizophrenia: analysis of total and phosphorylated tyrosine hydroxylase in the substantia nigra. Front Psychiatry (2012) 0.95

Aberrant extracellular signal-regulated kinase (ERK)1/2 signalling in suicide brain: role of ERK kinase 1 (MEK1). Int J Neuropsychopharmacol (2009) 0.94

Preparative two-dimensional gel electrophoresis at alkaline pH using narrow range immobilized pH gradients. Proteomics (2002) 0.94

Cyclic AMP response element-binding protein in post-mortem brain of teenage suicide victims: specific decrease in the prefrontal cortex but not the hippocampus. Int J Neuropsychopharmacol (2006) 0.94

mRNA and protein expression of selective alpha subunits of G proteins are abnormal in prefrontal cortex of suicide victims. Neuropsychopharmacology (2002) 0.93

Altered expression and phosphorylation of myristoylated alanine-rich C kinase substrate (MARCKS) in postmortem brain of suicide victims with or without depression. J Psychiatr Res (2003) 0.92

Mitochondrial viability in mouse and human postmortem brain. FASEB J (2010) 0.92

Light and electron microscopy study of glycogen synthase kinase-3beta in the mouse brain. PLoS One (2010) 0.92

Lower phosphoinositide 3-kinase (PI 3-kinase) activity and differential expression levels of selective catalytic and regulatory PI 3-kinase subunit isoforms in prefrontal cortex and hippocampus of suicide subjects. Neuropsychopharmacology (2007) 0.91

Neuroleptics and animal models: feasibility of oral treatment monitored by plasma levels and receptor occupancy assays. J Neural Transm (Vienna) (2008) 0.91

Magnetic transfer contrast accurately localizes substantia nigra confirmed by histology. Biol Psychiatry (2012) 0.90

Dopamine transporter polymorphism modulates oculomotor function and DAT1 mRNA expression in schizophrenia. Am J Med Genet B Neuropsychiatr Genet (2009) 0.90

Fatty acid composition of the postmortem prefrontal cortex of adolescent male and female suicide victims. Prostaglandins Leukot Essent Fatty Acids (2008) 0.85

5-Lipoxygenase in the Prefrontal Cortex of Suicide Victims. Open Neuropsychopharmacol J (2008) 0.84

Mitochondria in the striatum of subjects with schizophrenia: relationship to treatment response. Synapse (2011) 0.83

Mitochondria in the striatum of subjects with schizophrenia. World J Biol Psychiatry (2010) 0.83

GSK-3beta gene expression in human postmortem brain: regional distribution, effects of age and suicide. Neurochem Res (2008) 0.83

Neurochemical characterization of the tree shrew dorsal striatum. Front Neuroanat (2011) 0.82

A new use for long-term frozen brain tissue: golgi impregnation. J Neurosci Methods (2008) 0.82

Aberrant extracellular signal-regulated kinase (ERK) 5 signaling in hippocampus of suicide subjects. Neuropsychopharmacology (2007) 0.81

Dual use of immunohistochemistry for film densitometry and light microscopy. J Neurosci Methods (2012) 0.77

Immunohistochemical localization of enkephalin in the human striatum: a postmortem ultrastructural study. Synapse (2011) 0.77

The immunocytochemical localization of substance P in the human striatum: a postmortem ultrastructural study. Synapse (2005) 0.76

Glycogen synthase kinase-3β (GSK3β) expression in a mouse model of Alzheimer's disease: a light and electron microscopy study. Synapse (2013) 0.76